 |
Video: What is a Stock Split?
|
 |
Bio-Path Holdings, Inc. is a biotechnology company. Co. is engaged in developing DNAbilize, a novel technology that has yielded a pipeline of RNAi nanoparticle drugs that can be administered with a simple intravenous transfusion. DNAbilize, is a platform that uses P-ethoxy, which is a deoxyribonucleic acid (DNA) backbone modification that is intended to protect the DNA from destruction by the body's enzymes when circulating in vivo, incorporated inside of a lipid bilayer having neutral charge. According to our BPTH split history records, Bio-Path Holdings has had 3 splits. | |
 |

Bio-Path Holdings (BPTH) has 3 splits in our BPTH split history database. The first split for BPTH took place on February 09, 2018. This was a 1 for 10 reverse split, meaning for each 10 shares of BPTH owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 100 share position following the split. BPTH's second split took place on January 18, 2019. This was a 1 for 20 reverse split, meaning for each 20 shares of BPTH owned pre-split, the shareholder now owned 1 share. For example, a 100 share position pre-split, became a 5 share position following the split. BPTH's third split took place on February 23, 2024. This was a 1 for 20 reverse split, meaning for each 20 shares of BPTH owned pre-split, the shareholder now owned 1 share. For example, a 5 share position pre-split, became a 0.25 share position following the split.
When a company such as Bio-Path Holdings conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the BPTH split history from start to finish, an original position size of 1000 shares would have turned into 0.25 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Bio-Path Holdings shares, starting with a $10,000 purchase of BPTH, presented on a split-history-adjusted basis factoring in the complete BPTH split history.

Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
02/17/2015 |
|
End date: |
02/12/2025 |
|
Start price/share: |
$8,600.00 |
|
End price/share: |
$0.72 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-99.99% |
|
Average Annual Total Return: |
-60.91% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$0.84 |
|
Years: |
9.99 |
|
|
 |
Date |
Ratio |
02/09/2018 | 1 for 10 | 01/18/2019 | 1 for 20 | 02/23/2024 | 1 for 20 |
|
 |